Main Article Content
Vaccines are a billion dollars business, WHO reports that the Vaccine market has grown exponentially in past few years. It was worth 5 billion in year 2000 enhancing to 24 Billion in 2013 with market growth of 10-15% per year compared to 5-7% for the pharmaceuticals and the market volume of Vaccine in 2020 is around 60 billion US dollars. More than 100 companies had been working on Corona vaccine across the globe. The Russian President Vladimir Putin announced in August this year the discovery of Corona Vaccine including his daughter to be one of trial subject. Chinese have also developed the vaccine and are conducting phase 3 trials including in Pakistan. UK and some other countries are working on similar plans, however none of these could get a response as favorable and the one announced by Pfizer on 9th November 2020.
Work published in KMUJ is licensed under a
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
World Health Organization. Global Vaccine Market Report. [Accessed on: November 16, 2020]. Available from URL: https://www.who.int/immunization/programmes_systems/procurement/mi4a/platform/module2/MI4A_Global_Vaccine_Market_Report.pdf
Pharmaceutical Processing World. Global Vaccine Market Revenue to Reach $59.2 Billion by 2020 - Pharmaceutical Processing World. May 2019 [Accessed on: November 16, 2020]. Available from URL: https://www.pharmaceuticalprocessingworld.com/global-vaccine-market-revenue-to-reach-59-2-billion-by-2020/
World Health Organization. 172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility. [Accessed on: November 16, 2020]. Available from URL: https://www.who.int/news/item/24-08-2020-172-countries-and-multiple-candidate-vaccines-engaged-in-covid-19-vaccine-global-access-facility
BBC News. Coronavirus: Putin says vaccine has been approved for use. [Accessed on: November 16, 2020]. Available from URL: https://www.bbc.com/news/world-europe-53735718
Dawn News. Phase 3 clinical trial for vaccine being developed by China begins in Pakistan. [Accessed on: November 16, 2020]. Available from URL: https://www.dawn.com/news/1581021
Pfizer. Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study. [Accessed on: November 16, 2020]. Available from URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against
Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Zolfaghari, Emameh R, et al. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microb Pathog 2020;104554. DOI: 10.1016/j.micpath.2020.104554.
Leitner W, Ying H, Restifo N. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 1999;18(9-10):765-77. DOI:10.1016/s0264-410x(99)00271-6
Nature. The coronavirus is mutating — does it matter? [Accessed on: November 16, 2020]. Available from URL: https://www.nature.com/articles/d41586-020-02544-6
Apicella M, Campopiano M, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 2020;8(9):782-92. DOI: 10.1016/S2213-8587(20)30238-2.
The Guardian. Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant. [Accessed on: November 16, 2020]. Available from URL: https://www.theguardian.com/world/2020/sep/09/oxford-university-astrazeneca-covid-vaccine-trial-put-on-hold-due-to-adverse-reaction-in-participant
Chronicles SF. Pfizer vaccine needs to be stored at minus 94 degrees Fahrenheit. Is the Bay
Area prepared to do that? [Accessed on: November 16, 2020]. Available from URL: https://www.sfchronicle.com/bayarea/article/Some-coronavirus-vaccines-need-to-be-stored-at-15711275.php
Wise J. Covid-19: Health and care workers will be “highest priority” for vaccination, says JCVI. BMJ 2020;369:m2477. DOI: 10.1136/bmj.m2477.